Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units
<b>Background</b>: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. <b>Methods:</b> Description of aminoglycosides prescrip...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4ac2fb44f8b548ebbdc3e9c73b5c20e2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4ac2fb44f8b548ebbdc3e9c73b5c20e2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4ac2fb44f8b548ebbdc3e9c73b5c20e22021-11-25T16:25:11ZPrescription of Aminoglycosides in 23 French Neonatal Intensive Care Units10.3390/antibiotics101114222079-6382https://doaj.org/article/4ac2fb44f8b548ebbdc3e9c73b5c20e22021-11-01T00:00:00Zhttps://www.mdpi.com/2079-6382/10/11/1422https://doaj.org/toc/2079-6382<b>Background</b>: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. <b>Methods:</b> Description of aminoglycosides prescriptions in 23 French NICU using the same computerized system over a 4-year period (2017–2020). A benchmarking program of antibiotics prescription was associated. <b>Results:</b> The population included 53,818 patients. Exposition rates to gentamicin and amikacin were 31.7% (<i>n</i> = 17,049) and 9.1% (<i>n</i> = 4894), respectively. Among neonates exposed to gentamicin, 90.4% of gentamicin and 77.6% of amikacin treatments were started within the 1st week of life. Among neonates exposed to amikacin, 77.6% started amikacin within the 1st week. The average daily dose of gentamicin at first prescription increased over the study period from 3.9 in 2017 to 4.4 mg/kg/d in 2020 (<i>p</i> < 0.0001). Conversely, the corresponding amikacin daily doses decreased from 13.0 in 2017 to 12.3 mg/kg/d in 2020 (<i>p</i> = 0.001). The time interval between the first 2 doses of gentamicin was mainly distributed in 3 values during the first week of life: 49.4% at 24 h, 26.4% at 36 h, and 22.9% at 48 h. At first amikacin prescription, the time interval was distributed in 4 categories: 48% at 24 h, 4.1% at 30 h, 8.5% at 36 h, and 37.1% at 48 h. As compared to literature guidelines, the rates of overdose and underdose in gentamicin (1.5% and 2.7%) and amikacin (0.3% and 1.0%). They significantly decreased for gentamicin over the study period. In multivariate analysis, the factors significantly associated with GENT overdose were the year of admission, prematurity, length of stay, and duration of the treatment. <b>Conclusion:</b> This prescription strategy ensured a low rate of overdose and underdose, and some benefits of the benchmarking program is suggested.Séverine Martin-MonsBéatrice GouyonSéverine LorrainSoumeth AbasseCénéric AlexandreGuillaume BinsonRoselyne BratLaurence CaeymaexYvan CouringaCécile DesbruyeresMarine Dorsi-Di MeglioGuillaume EscourrouFlorence FlameinOlivier FlechellesOlivier GirardElsa Kermorvant-DucheminAlexandre LapillonneCatherine LafonMassimo Di MaioGaël MazeirasJulien MourdieAmélie Moussy-DurandyAnne-Sophie PagesDuksha RamfulHasinirina RazafimahefaJean-Marc RosenthalSilvia IacobelliJean-Bernard GouyonMDPI AGarticlen/aTherapeutics. PharmacologyRM1-950ENAntibiotics, Vol 10, Iss 1422, p 1422 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
n/a Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
n/a Therapeutics. Pharmacology RM1-950 Séverine Martin-Mons Béatrice Gouyon Séverine Lorrain Soumeth Abasse Cénéric Alexandre Guillaume Binson Roselyne Brat Laurence Caeymaex Yvan Couringa Cécile Desbruyeres Marine Dorsi-Di Meglio Guillaume Escourrou Florence Flamein Olivier Flechelles Olivier Girard Elsa Kermorvant-Duchemin Alexandre Lapillonne Catherine Lafon Massimo Di Maio Gaël Mazeiras Julien Mourdie Amélie Moussy-Durandy Anne-Sophie Pages Duksha Ramful Hasinirina Razafimahefa Jean-Marc Rosenthal Silvia Iacobelli Jean-Bernard Gouyon Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| description |
<b>Background</b>: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to antibiotics in the NICU is highly desirable, particularly through benchmarking methods. <b>Methods:</b> Description of aminoglycosides prescriptions in 23 French NICU using the same computerized system over a 4-year period (2017–2020). A benchmarking program of antibiotics prescription was associated. <b>Results:</b> The population included 53,818 patients. Exposition rates to gentamicin and amikacin were 31.7% (<i>n</i> = 17,049) and 9.1% (<i>n</i> = 4894), respectively. Among neonates exposed to gentamicin, 90.4% of gentamicin and 77.6% of amikacin treatments were started within the 1st week of life. Among neonates exposed to amikacin, 77.6% started amikacin within the 1st week. The average daily dose of gentamicin at first prescription increased over the study period from 3.9 in 2017 to 4.4 mg/kg/d in 2020 (<i>p</i> < 0.0001). Conversely, the corresponding amikacin daily doses decreased from 13.0 in 2017 to 12.3 mg/kg/d in 2020 (<i>p</i> = 0.001). The time interval between the first 2 doses of gentamicin was mainly distributed in 3 values during the first week of life: 49.4% at 24 h, 26.4% at 36 h, and 22.9% at 48 h. At first amikacin prescription, the time interval was distributed in 4 categories: 48% at 24 h, 4.1% at 30 h, 8.5% at 36 h, and 37.1% at 48 h. As compared to literature guidelines, the rates of overdose and underdose in gentamicin (1.5% and 2.7%) and amikacin (0.3% and 1.0%). They significantly decreased for gentamicin over the study period. In multivariate analysis, the factors significantly associated with GENT overdose were the year of admission, prematurity, length of stay, and duration of the treatment. <b>Conclusion:</b> This prescription strategy ensured a low rate of overdose and underdose, and some benefits of the benchmarking program is suggested. |
| format |
article |
| author |
Séverine Martin-Mons Béatrice Gouyon Séverine Lorrain Soumeth Abasse Cénéric Alexandre Guillaume Binson Roselyne Brat Laurence Caeymaex Yvan Couringa Cécile Desbruyeres Marine Dorsi-Di Meglio Guillaume Escourrou Florence Flamein Olivier Flechelles Olivier Girard Elsa Kermorvant-Duchemin Alexandre Lapillonne Catherine Lafon Massimo Di Maio Gaël Mazeiras Julien Mourdie Amélie Moussy-Durandy Anne-Sophie Pages Duksha Ramful Hasinirina Razafimahefa Jean-Marc Rosenthal Silvia Iacobelli Jean-Bernard Gouyon |
| author_facet |
Séverine Martin-Mons Béatrice Gouyon Séverine Lorrain Soumeth Abasse Cénéric Alexandre Guillaume Binson Roselyne Brat Laurence Caeymaex Yvan Couringa Cécile Desbruyeres Marine Dorsi-Di Meglio Guillaume Escourrou Florence Flamein Olivier Flechelles Olivier Girard Elsa Kermorvant-Duchemin Alexandre Lapillonne Catherine Lafon Massimo Di Maio Gaël Mazeiras Julien Mourdie Amélie Moussy-Durandy Anne-Sophie Pages Duksha Ramful Hasinirina Razafimahefa Jean-Marc Rosenthal Silvia Iacobelli Jean-Bernard Gouyon |
| author_sort |
Séverine Martin-Mons |
| title |
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| title_short |
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| title_full |
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| title_fullStr |
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| title_full_unstemmed |
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units |
| title_sort |
prescription of aminoglycosides in 23 french neonatal intensive care units |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/4ac2fb44f8b548ebbdc3e9c73b5c20e2 |
| work_keys_str_mv |
AT severinemartinmons prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT beatricegouyon prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT severinelorrain prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT soumethabasse prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT cenericalexandre prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT guillaumebinson prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT roselynebrat prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT laurencecaeymaex prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT yvancouringa prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT ceciledesbruyeres prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT marinedorsidimeglio prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT guillaumeescourrou prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT florenceflamein prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT olivierflechelles prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT oliviergirard prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT elsakermorvantduchemin prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT alexandrelapillonne prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT catherinelafon prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT massimodimaio prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT gaelmazeiras prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT julienmourdie prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT ameliemoussydurandy prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT annesophiepages prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT duksharamful prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT hasinirinarazafimahefa prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT jeanmarcrosenthal prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT silviaiacobelli prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits AT jeanbernardgouyon prescriptionofaminoglycosidesin23frenchneonatalintensivecareunits |
| _version_ |
1718413197407420416 |